This Surprising Test Could Change Cancer Treatment
12 Oct 2025 · 1 min
0:30
In this brief promotional video, Dr. Dino Prado, founder of Envita Medical Centers, argues that cancer patients are not a homogeneous group; each individual's cancer is unique. He criticizes the prevailing one‑size‑fits‑all approach that treats patients based solely on cancer type. Prado explains that detailed molecular and functional testing can reveal each patient’s specific targets, which then enables the use of much lower doses of chemotherapy combined with immuno‑targeting and natural integrative agents. The video ends with a call to action, inviting viewers to learn more at envita.com.
